TW200605917A - Spray-dried powder comprising at least one 1,4 o-linked saccharose-derivative and methods for their preparation - Google Patents
Spray-dried powder comprising at least one 1,4 o-linked saccharose-derivative and methods for their preparationInfo
- Publication number
- TW200605917A TW200605917A TW094114826A TW94114826A TW200605917A TW 200605917 A TW200605917 A TW 200605917A TW 094114826 A TW094114826 A TW 094114826A TW 94114826 A TW94114826 A TW 94114826A TW 200605917 A TW200605917 A TW 200605917A
- Authority
- TW
- Taiwan
- Prior art keywords
- spray
- linked
- dried powder
- saccharose
- derivative
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Immunology (AREA)
- Otolaryngology (AREA)
- Pulmonology (AREA)
- Medicinal Preparation (AREA)
Abstract
The present invention relates to a spray-dried powder and method for its manufacture. A spray-dried powder containing a pharmaceutical active substance and one or more of 1,4 O-linked saccharose derivatives chosen from the compounds: 1,4 O-linked D-gal-saccharose (lactosucrose), 1,4 O-linked D-glu-saccharose (glucosyl sucrose) or 1,4 O-linked glu-glu-saccharose (maltosyl sucrose). Preferred combinations are such that they contain glucosyl and maltosyl sucrose.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102004022926A DE102004022926A1 (en) | 2004-05-10 | 2004-05-10 | Spray-dried powders containing at least one 1,4 O-linked sucrose derivative and process for their preparation |
Publications (1)
Publication Number | Publication Date |
---|---|
TW200605917A true TW200605917A (en) | 2006-02-16 |
Family
ID=34966513
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW094114826A TW200605917A (en) | 2004-05-10 | 2005-05-09 | Spray-dried powder comprising at least one 1,4 o-linked saccharose-derivative and methods for their preparation |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1778188A1 (en) |
JP (1) | JP2007536313A (en) |
KR (1) | KR20070037441A (en) |
CA (1) | CA2564324A1 (en) |
DE (1) | DE102004022926A1 (en) |
TW (1) | TW200605917A (en) |
WO (1) | WO2005112892A1 (en) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7611709B2 (en) | 2004-05-10 | 2009-11-03 | Boehringer Ingelheim Pharma Gmbh And Co. Kg | 1,4 O-linked saccharose derivatives for stabilization of antibodies or antibody derivatives |
CN101304970A (en) * | 2005-12-21 | 2008-11-12 | 卫材R&D管理有限公司 | Amorphous form of 1,2-dihydropyridine compound |
EP2077132A1 (en) | 2008-01-02 | 2009-07-08 | Boehringer Ingelheim Pharma GmbH & Co. KG | Dispensing device, storage device and method for dispensing a formulation |
CA2744655A1 (en) * | 2008-11-27 | 2010-06-03 | Boehringer Ingelheim International Gmbh | Novel powdered crystalline medicines for inhalation |
WO2010112358A2 (en) | 2009-03-31 | 2010-10-07 | Boehringer Ingelheim International Gmbh | Method for coating a surface of a component |
JP5763053B2 (en) | 2009-05-18 | 2015-08-12 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Adapter, inhaler and atomizer |
EA026241B1 (en) | 2009-11-25 | 2017-03-31 | Бёрингер Ингельхайм Интернациональ Гмбх | Nebulizer |
JP5658268B2 (en) | 2009-11-25 | 2015-01-21 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Nebulizer |
US10016568B2 (en) | 2009-11-25 | 2018-07-10 | Boehringer Ingelheim International Gmbh | Nebulizer |
JP5874724B2 (en) | 2010-06-24 | 2016-03-02 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Nebulizer |
WO2012130757A1 (en) | 2011-04-01 | 2012-10-04 | Boehringer Ingelheim International Gmbh | Medical device comprising a container |
US9827384B2 (en) | 2011-05-23 | 2017-11-28 | Boehringer Ingelheim International Gmbh | Nebulizer |
WO2013152894A1 (en) | 2012-04-13 | 2013-10-17 | Boehringer Ingelheim International Gmbh | Atomiser with coding means |
US9744313B2 (en) | 2013-08-09 | 2017-08-29 | Boehringer Ingelheim International Gmbh | Nebulizer |
EP2835146B1 (en) | 2013-08-09 | 2020-09-30 | Boehringer Ingelheim International GmbH | Nebulizer |
DK3139979T3 (en) | 2014-05-07 | 2023-10-09 | Boehringer Ingelheim Int | DEVICE, ATOMIZER AND PROCEDURE |
NZ724449A (en) | 2014-05-07 | 2022-01-28 | Boehringer Ingelheim Int | Nebulizer and container |
EP3139984B1 (en) | 2014-05-07 | 2021-04-28 | Boehringer Ingelheim International GmbH | Nebulizer |
CN107106641B (en) | 2014-10-31 | 2021-12-21 | 葛兰素史密斯克莱知识产权发展有限公司 | Powder formulation |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5012272A (en) * | 1973-06-01 | 1975-02-07 | ||
DE69111271T2 (en) * | 1990-03-08 | 1996-02-22 | Ensuiko Sugar Refining | Process for the preparation of a powder / with an increased content of lactosucrose and use of this powder. |
US6582728B1 (en) * | 1992-07-08 | 2003-06-24 | Inhale Therapeutic Systems, Inc. | Spray drying of macromolecules to produce inhaleable dry powders |
JPH0776527A (en) * | 1993-06-28 | 1995-03-20 | Hayashibara Biochem Lab Inc | Semi-solid preparation and production thereof |
AU699715B2 (en) * | 1994-01-31 | 1998-12-10 | Astellas Pharma Inc. | Intrabuccally dissolving compressed moldings and production process thereof |
US6051256A (en) * | 1994-03-07 | 2000-04-18 | Inhale Therapeutic Systems | Dispersible macromolecule compositions and methods for their preparation and use |
US5955448A (en) * | 1994-08-19 | 1999-09-21 | Quadrant Holdings Cambridge Limited | Method for stabilization of biological substances during drying and subsequent storage and compositions thereof |
US5922324A (en) * | 1995-01-31 | 1999-07-13 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Propolis extract with improved water-solubility |
US5892026A (en) * | 1995-04-12 | 1999-04-06 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | High Trehalose content syrup |
US6258341B1 (en) * | 1995-04-14 | 2001-07-10 | Inhale Therapeutic Systems, Inc. | Stable glassy state powder formulations |
DE19732351A1 (en) * | 1997-07-28 | 1999-02-04 | Hoechst Ag | Increasing sweetness and enhancing taste of high-intensity sweetener mixtures |
AU2002241723A1 (en) * | 2000-12-21 | 2002-07-24 | Inhale Therapeutic Systems, Inc. | Storage stable powder compositions of interleukin-4 receptor |
-
2004
- 2004-05-10 DE DE102004022926A patent/DE102004022926A1/en not_active Withdrawn
-
2005
- 2005-05-04 WO PCT/EP2005/004806 patent/WO2005112892A1/en active Application Filing
- 2005-05-04 JP JP2007512007A patent/JP2007536313A/en active Pending
- 2005-05-04 CA CA002564324A patent/CA2564324A1/en not_active Abandoned
- 2005-05-04 KR KR1020067025973A patent/KR20070037441A/en not_active Application Discontinuation
- 2005-05-04 EP EP05738129A patent/EP1778188A1/en not_active Withdrawn
- 2005-05-09 TW TW094114826A patent/TW200605917A/en unknown
Also Published As
Publication number | Publication date |
---|---|
JP2007536313A (en) | 2007-12-13 |
CA2564324A1 (en) | 2005-12-01 |
WO2005112892A1 (en) | 2005-12-01 |
KR20070037441A (en) | 2007-04-04 |
DE102004022926A1 (en) | 2005-12-15 |
EP1778188A1 (en) | 2007-05-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW200605917A (en) | Spray-dried powder comprising at least one 1,4 o-linked saccharose-derivative and methods for their preparation | |
TW200605905A (en) | 1,4 o-linked saccharose derivatives for stabilization of antibodies or antibody derivatives | |
ATE383850T1 (en) | POWDER CONTAINING NOVEL OLIGOSACCHARIDE MIXTURES AND METHOD FOR THE PRODUCTION THEREOF | |
NO20064596L (en) | Delta crystalline form of ivabradine hydrochloride, process for its preparation and pharmaceutical compositions containing the | |
NO20060947L (en) | β d-crystalline form of ivabradine hydrochloride, process for its preparation and pharmaceutical compositions containing the | |
AU2003244632A1 (en) | Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them | |
UA86595C2 (en) | Gamma-crystalline form of the chlorohydrate of ivabradine, process for its preparation and pharmaceutical compositions containing it | |
UA86413C2 (en) | Normal;heading 1;heading 2;SUGAR COATING AND SOLID DOSAGE FORM CONTAINING THEREOF | |
WO2007090882A3 (en) | Pharmaceutical extended release compositions comprising pramipexole | |
HK1076605A1 (en) | Formulations | |
WO2005046603A3 (en) | Pyridine compounds | |
MXPA03010207A (en) | Novel 4-anilinoquinoline-3-carboxamides. | |
WO2002074247A3 (en) | Pharmaceutical formulations for sustained release | |
AU2003244649A1 (en) | Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them | |
IL168266A (en) | Nucleoside derivatives, processes for their preparation. pharmaceutical compositions comprising them and uses thereof for the manufacture of medicaments | |
NO20051414L (en) | Process for the preparation of dry powder inhalation compositions | |
WO2007076085A3 (en) | Fused pyrimidones and thiopyrimidones, and uses thereof | |
WO2006096444A3 (en) | Chemical compounds | |
WO2001029055A3 (en) | Novel oligosaccharides, preparation method and pharmaceutical compositions containing same | |
WO2004093800A3 (en) | Thyronamine derivatives and analogs and methods of use thereof | |
HUP0303763A3 (en) | Substituted imidazoles as tafia inhibitors, process for their preparation and pharmaceutical compositions containing them | |
WO2006028810A3 (en) | Method of wound healing using a2b adenosine receptor antagonists | |
AU2002358676A1 (en) | Hydroxyphenyl-pyrazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them | |
WO2004098594A3 (en) | Dosage form containing pantoprazole as active ingredient | |
WO2001000617A3 (en) | Novel piperazinylalkylthiopyrimidine derivatives, pharmaceutical compositions containing the same, and a process for the preparation of the same |